Is SURG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SURG. It does not provide personalized investment advice.

SURG (SurgePays, Inc. Common Stock) Stock Analysis - Financials

SurgePays, Inc. Common Stock (SURG) is a publicly traded Technology sector company. As of October 29, 2026, SURG trades at $0.17 with a market cap of $7.75M and a P/E ratio of -0.08. SURG moved +11.02% today. Year to date, SURG is -90.98%; over the trailing twelve months it is -94.70%. Its 52-week range spans $0.11 to $3.47. Analyst consensus is buy with an average price target of $3.75. Rallies surfaces SURG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SURG's key financials?

SURG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SURG recently traded at $0.17. Market cap is $7.75M. P/E ratio is -0.08. Revenue is $56.96M.

SURG Key Metrics

Key financial metrics for SURG
Metric	Value
Price	$0.17
Market Cap	$7.75M
P/E Ratio	-0.08
EPS	$-1.80
Dividend Yield	0.00%
52-Week High	$3.47
52-Week Low	$0.11
Volume	4.65M
Avg Volume	0
Revenue (TTM)	$56.96M
Net Income	$-36.07M
Gross Margin	-18.59%

SURG Analyst Consensus

1 analysts cover SURG: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.75.

Common questions about SURG

What are SURG's key financials?: SURG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SURG recently traded at $0.17. Market cap is $7.75M. P/E ratio is -0.08. Revenue is $56.96M.
Is SURG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SURG. It does not provide personalized investment advice.